Table 2.
SSTR2 expression in glioma subtypes
| Diagnosis | SSTR2 expression | SSTR2 expression | Total | ||
|---|---|---|---|---|---|
|
|
|
||||
| negative | positive | low | high | ||
| glioblastoma | 83 (63.36%) | 48 (36.64%) | 120 (91.60%) | 11 (8.40%) | 131 |
| anaplastic oligodendroglioma | 10 (31.25%) | 22 (68.75%) | 21 (65.63%) | 11 (34.38%) | 32 |
| oligodendroglioma | 4 (18.19%) | 18 (81.81%) | 10 (45.45%) | 12 (54.55%) | 22 |
| astrocytoma | 26 (44.97%) | 33 (55.93%) | 33 (55.93%) | 26 (44.07%) | 59 |
| anaplastic astrocytoma | 20 (45.45%) | 24 (54.55%) | 35 (79.55%) | 9 (20.45%) | 44 |
| pilocytic astrocytoma | 11 (78.57%) | 3 (21.43%) | 11 (78.57%) | 3 (21.43%) | 14 |